| Company Name: |
Hefei KS-V Peptide Biotechnology Co., Ltd. Gold
|
| Tel: |
0551-65120828 17368858770 |
| Email: |
sales1@difficultpeptide.com |
| Products Intro: |
Product Name:Muscarinic toxin 7
Purity:≥95%,1mg/5mg/10mg Package:1g/;1mg/
|
| Company Name: |
Hangzhou Peptidego Biotech Co.,Ltd.
|
| Tel: |
0571-87213919 |
| Email: |
Eric@peptidego.com |
| Products Intro: |
Product Name:Muscarinic toxin 7
Purity:95% or 98% HPLC Package:1mg；5mg；10mg；50mg；100mg,1g or according to customer's detail requirement.
|
Muscarinic toxin 7 manufacturers
- MT-7
-
- $1980.00 / 50mg
-
2026-01-05
- CAS:946507-08-0
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| | Muscarinic toxin 7 Basic information |
| Product Name: | Muscarinic toxin 7 | | Synonyms: | LEU-THR-CYS-VAL-LYS-SER-ASN-SER-ILE-TRP-PHE-PRO-THR-SER-GLU-ASP-CYS-PRO-ASP-GLY-GLN-ASN-LEU-CYS-PHE-LYS-ARG-TRP-GLN-TYR-ILE-SER-PRO-ARG-MET-TYR-ASP-PHE-THR-ARG-GLY-CYS-ALA-ALA-THR-CYS-PRO-LYS-ALA-GLU-TYR-ARG-ASP-VAL-ILE-ASN-CYS-CYS-GLY-THR-ASP-LYS-CYS-ASN-LYS;M1-TOXIN1;MTX7;MT7;MUSCARINIC TOXIN 7 | | CAS: | 946507-08-0 | | MF: | C22H17N3O2 | | MW: | 355.4 | | EINECS: | | | Product Categories: | | | Mol File: | 946507-08-0.mol |  |
| | Muscarinic toxin 7 Chemical Properties |
| InChI | InChI=1S/C22H17N3O2/c1-27-16-11-9-15(10-12-16)14-25-21-20(23-19-8-4-5-13-24(19)21)17-6-2-3-7-18(17)22(25)26/h2-13H,14H2,1H3 | | InChIKey | FQBICJMKIGUPQG-UHFFFAOYSA-N | | SMILES | C(C1C=CC(OC)=CC=1)N1C(C2=CC=CC=C2C2N=C3C=CC=CN3C1=2)=O |
| | Muscarinic toxin 7 Usage And Synthesis |
| Uses | MT-7 is a potent mitotic inhibitor. MT-7 shows antiproliferative activity. MT-7 induces cell cycle arrest at G2/M phase. MT-7 induces specific, reversible mitotic arrest and inhibits the polymerization of cellular microtubules[1]. | | References | [1] Zhang Z, et al. MT7, a novel compound from a combinatorial library, arrests mitosis via inhibiting the polymerization of microtubules. Invest New Drugs. 2010 Dec;28(6):715-28. DOI:10.1007/s10637-009-9303-z |
| | Muscarinic toxin 7 Preparation Products And Raw materials |
|